Our expertise

Our team brings extensive experience in testing a wide range of therapeutics using animal models for type 1 diabetes, e.g., NOD mice. With a comprehensive suite of read-outs and data analysis capabilities, paired with cutting-edge facilities and technology platforms, we are equipped to conduct both proof-of-concept studies and larger, more complex experiments to evaluate innovative therapies.

Leveraging deep expertise in clinical translation, we offer a broad range of services, including human peripheral blood mononuclear cell (PBMC) isolation, cryopreservation, biobanking, and supporting clinical trials—all backed by a proven track record of success. We receive fresh blood samples from healthy controls and people living with type 1 diabetes.

We specialize in immunophenotyping, enabling precise identification of cells based on surface protein expression. Our extensive flow cytometry services—both conventional and spectral—are available for the analysis of isolated peripheral blood mononuclear cells (PBMCs) and whole blood. These include pre-designed panels as well as tailored solutions to support your exploratory and clinical biomarker studies.